RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
| Status: | Recruiting |
|---|---|
| Conditions: | Chronic Pain |
| Therapuetic Areas: | Musculoskeletal |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/13/2019 |
| Start Date: | May 2013 |
| End Date: | December 2020 |
| Contact: | Ann Masuda, M.S. |
| Email: | Ann.Masuda@bsci.com |
| Phone: | (661) 949-4726 |
A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially
approved neurostimulation systems for pain in routine clinical practice, when used according
to the applicable Directions for Use
- and -
To evaluate the economic value and technical performance of Boston Scientific commercially
approved neurostimulation systems for pain in routine clinical practice
approved neurostimulation systems for pain in routine clinical practice, when used according
to the applicable Directions for Use
- and -
To evaluate the economic value and technical performance of Boston Scientific commercially
approved neurostimulation systems for pain in routine clinical practice
The study is a prospective, multi-center, global registry of Boston Scientific
neurostimulation systems for pain.
The study treatment will consist of neurostimulation trial therapy with any commercially
approved Boston Scientific Corporation neurostimulator for pain. Positive trials, subjects
with a successful trial outcome, may progress to permanent implant of a neurostimulation
system. Individualization of neurostimulation therapy for pain will be determined according
to investigator discretion and site routine care, and in accordance with inclusion and
exclusion criteria.
neurostimulation systems for pain.
The study treatment will consist of neurostimulation trial therapy with any commercially
approved Boston Scientific Corporation neurostimulator for pain. Positive trials, subjects
with a successful trial outcome, may progress to permanent implant of a neurostimulation
system. Individualization of neurostimulation therapy for pain will be determined according
to investigator discretion and site routine care, and in accordance with inclusion and
exclusion criteria.
Key Inclusion Criteria:
- Study candidate is scheduled to be trialed, on-label, with a commercially approved
Boston Scientific neurostimulation system for pain, per local directions for use
- Signed a valid, IRB/EC-approved informed consent form
- 18 years of age or older
Key Exclusion Criteria:
- Contraindicated for Boston Scientific neurostimulation system
- Currently diagnosed with cognitive impairment, or exhibits any characteristic, that
would limit study candidate's ability to assess pain relief or to complete study
assessments
We found this trial at
1
site
Valencia, California 91355
Phone: 855-213-9890
Click here to add this to my saved trials
